News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Daily News FDA Approves Two Additional Indications for Rivaroxaban in Children L.A. McKeown December 21, 2021
News Daily News PASCAL Pinpoints Patients With Strokes Causally Related to PFO Yael L. Maxwell December 20, 2021
News Daily News Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation Todd Neale November 25, 2021
News Daily News Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR Yael L. Maxwell November 03, 2021
News Daily News Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed Yael L. Maxwell November 02, 2021
News Daily News Predictors of AF May Help Guide Care After Stroke of Unknown Cause Caitlin E. Cox October 26, 2021
News Daily News AHA Policy Statement Focuses on Gaps in STEMI Systems of Care L.A. McKeown October 18, 2021
News Daily News HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients Yael L. Maxwell October 12, 2021
News Daily News Rivaroxaban Again Linked to More Bleeding vs Other DOACs Caitlin E. Cox October 11, 2021
News Daily News AHA: More Screening Needed to Catch Myocardial Injury After Noncardiac Surgery Yael L. Maxwell October 04, 2021
News Daily News Even as COVID-19 Care Improved in NYC, Troponin Still Signaled Higher Mortality Caitlin E. Cox September 28, 2021